Recent Finacing
Recent Raise
4TEEN4 Pharmaceuticals is a Berlin-based biotech developing Procizumab, a monoclonal antibody aimed at treating cardiogenic shock by neutralizing circulating dipeptidyl peptidase 3 (cDPP3).
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at 4TEEN4 Pharmaceuticals.
